GEP19991639B - DNA-Sequence, Cell, Vector, Polypeptide, Method for Obtaining and Pharmaceutical Formulation - Google Patents

DNA-Sequence, Cell, Vector, Polypeptide, Method for Obtaining and Pharmaceutical Formulation

Info

Publication number
GEP19991639B
GEP19991639B GEAP1993984A GEAP1993000984A GEP19991639B GE P19991639 B GEP19991639 B GE P19991639B GE AP1993984 A GEAP1993984 A GE AP1993984A GE AP1993000984 A GEAP1993000984 A GE AP1993000984A GE P19991639 B GEP19991639 B GE P19991639B
Authority
GE
Georgia
Prior art keywords
epo
polypeptides
dna sequences
dna
polypeptide
Prior art date
Application number
GEAP1993984A
Other languages
English (en)
Inventor
Fu-Kuen Lin
Original Assignee
Kirin Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27097052&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GEP19991639(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/675,298 external-priority patent/US4703008A/en
Priority claimed from UA3917560A external-priority patent/UA54363C2/uk
Application filed by Kirin Amgen Inc filed Critical Kirin Amgen Inc
Publication of GEP19991639B publication Critical patent/GEP19991639B/en

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GEAP1993984A 1984-09-28 1993-07-09 DNA-Sequence, Cell, Vector, Polypeptide, Method for Obtaining and Pharmaceutical Formulation GEP19991639B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65584184A 1984-09-28 1984-09-28
US06/675,298 US4703008A (en) 1983-12-13 1984-11-30 DNA sequences encoding erythropoietin
UA3917560A UA54363C2 (uk) 1984-09-28 1985-06-19 Виділена молекула днк, яка кодує людський еритропоетин (варіанти), біологічно функціональний кільцевий плазмідний або вірусний днк-вектор, штам еукаріотичних клітин-хазяїв (варіанти), спосіб одержання поліпептиду, фармацевтична композиція

Publications (1)

Publication Number Publication Date
GEP19991639B true GEP19991639B (en) 1999-03-23

Family

ID=27097052

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP1993984A GEP19991639B (en) 1984-09-28 1993-07-09 DNA-Sequence, Cell, Vector, Polypeptide, Method for Obtaining and Pharmaceutical Formulation

Country Status (9)

Country Link
CN (1) CN1016795B (enrdf_load_stackoverflow)
CZ (1) CZ281542B6 (enrdf_load_stackoverflow)
FI (1) FI93470C (enrdf_load_stackoverflow)
GE (1) GEP19991639B (enrdf_load_stackoverflow)
GR (1) GR852245B (enrdf_load_stackoverflow)
HU (1) HU204889B (enrdf_load_stackoverflow)
NO (1) NO852384L (enrdf_load_stackoverflow)
PT (1) PT81213B (enrdf_load_stackoverflow)
SK (1) SK279959B6 (enrdf_load_stackoverflow)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106608906A (zh) * 2015-10-22 2017-05-03 天津药物研究院有限公司 一种具有刺激红细胞生成功能的环形多肽的制备及其应用

Also Published As

Publication number Publication date
PT81213B (pt) 1987-09-30
FI852377A0 (fi) 1985-06-14
FI93470B (fi) 1994-12-30
HUT40694A (en) 1987-01-28
SK443885A3 (en) 1999-06-11
FI852377L (fi) 1986-03-29
CN1016795B (zh) 1992-05-27
CZ443885A3 (en) 1996-09-11
CN85106191A (zh) 1987-07-29
CZ281542B6 (cs) 1996-11-13
GR852245B (enrdf_load_stackoverflow) 1986-01-17
SK279959B6 (sk) 1999-06-11
NO852384L (no) 1986-04-01
PT81213A (en) 1985-10-01
FI93470C (fi) 1995-04-10
HU204889B (en) 1992-02-28

Similar Documents

Publication Publication Date Title
NO20032250D0 (no) Anvendelse av et hpG-CSF-polypeptid til fremstilling av et medikament for åstanse proliferasjon av leukemiceller
ES8802329A1 (es) Un procedimiento para preparar un polipetido que tiene en parte o en su totalidad la conformacion estructural primaria de la critropoyetina de origen natural.
CZ738982A3 (en) Human immune interferon and derivative thereof, separated dna with sequence encoding human immune interferon, recombinant cloning vector, replicable expression vector, recombinant micro-organism or cellular culture, pharmaceutical preparation, process for preparing the human immune interferon and its use
BG60250B1 (bg) Метод за получаване на тумор некрозис фактор
NZ218332A (en) Il-4(interleukin-4), recombinant production, dna, vectors and pharmaceutical composition
IL88151A (en) Interleukin-7 protein, dna sequences encoding it, its preparation and compositions containing it
EP0275204A3 (en) Production of fibroblast growth factor
EP0111814A3 (en) The cloning and expression of nucleotide sequences encoding bovine growth hormone
EP2145961A3 (en) Porcine adenovirus type 3 genome
CA2083396A1 (en) Derivatives of human bile-salt stimulated lipase, and pharmaceutical compositions containing them
AU2002314183A1 (en) Method of plasmid stabilisation by in vivo deleting the antibiotic resistence and selecting with an essential gene
GEP19991639B (en) DNA-Sequence, Cell, Vector, Polypeptide, Method for Obtaining and Pharmaceutical Formulation
Souza Methods of treating bacterial inflammation and granulocytopoiesis by administering human pluripotent granulocyte colony-stimulating factor
DK200301683A (da) DNA-sekvens kodende for polypeptidet [la1]hpG-CSF, plasmider indeholdende sekvensen, hermed transformerede/transficerede værtsceller......